(Molly Bruns, Headline USA) The Food and Drug Administration has issued an official warning of potential vision loss and brain swelling for children that take puberty blockers, often used for sex-transitioning kids with increasing frequency in line with leftist social dogma.
Puberty blockers such as Lupron—which is used to castrate sex offenders—and others are used to suppress the onset of puberty in young children, Newsbusters reported.
In the medical field, they are referred to as gonadotropin-releasing hormone (GnRH) substances.
Many doctors and therapists who encourage children to transition at young ages preach that these drugs are “completely reversible,” but according to the FDA that is certianly not the case.
FDA officials said “five were undergoing treatment for central precocious puberty and one for transgender care,” and “the onset of pseudotumor cerebri symptoms ranged from three to 240 days” after the administration of the drugs.
Symptoms included “visual disturbances, headaches, and vomiting.” Additionally, “other GnRH agonists caused were an increase in blood pressure, brain swelling and adbucens neuropathy.”
The FDA also said it does not know “the mechanism by which GnRH agonists may lead to development of pseudotumor cerebri.”
The report also suggested that “this potential serious risk associated with GnRH agonists justifies inclusion in product labeling.”
According to The Daily Wire, the debate around these drugs has found its way to the center of the national stage after an interview with President Joe Biden’s U.S. Assistant Secretary of Health transgendered Rachel Levine.
Levine said that youth access to “gender affirming care” should not be limited by governmental or parental interference.
“Gender affirming care is life-saving, medically necessary, age-appropriate, and a critical tool for health care providers,” Levine said.
“As a pediatrician, when it comes to making sure kids are healthy and happy, I know how important care that affirms someone’s true identity can be.”
There are no long-term studies that show the potential for long-term or permanent effects of “puberty blocking” drugs.
